An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 174 participants.

Also called NCT03187522

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 174 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03187522
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT03187522. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06-22 (actual); primary completion 2020-12-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft
Condition
Aortic Aneurysm, Abdominal
Intervention (Device)
TREO Stent-Graft System
Lead sponsor
Bolton Medical (class: industry)
Collaborator
Bolton Medical Espana SLU (class: not stated)

Record details

Record id
cardio:ct-nct03187522
Content hash
5ba26636f17138c9fd4472700a65435bf08ef3645fb5c7ff0933425c0f49b4d0